Abstract
OV immunotherapy is an important emerging cancer treatment modality
which uses native or genetically modified viruses to destroy
cancers. MM is perhaps the ideal malignancy to target using OVs because
of the virus permissivity of neoplastic plasma cells and the
diseaseassociated
immune paresis. OVs have the potential to mediate both tumor debulking
and residual disease elimination avoiding the complex and
prolonged current therapy for multiple myeloma.
Oncolytic Virotherapy and Multiple Myeloma by Nahla AM Hamed in BJSTR
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.